Rani Therapeutics grants CFO Nicholas Maestas option for 2 million shares at $0.7 exercise price - RANI News | RalliesRani Therapeutics grants CFO Nicholas Maestas option for 2 million shares at $0.7 exercise price
R
RANI• CFO stock option grant details
- Rani Therapeutics granted CFO Nicholas Maestas a stock option for 2 million Class A shares on July 17, 2026.
- Exercise price set at USD 0.7 per share; option term runs 10 years.
- Award vests over four years, with 25% vesting after one year; remainder vests monthly over the next 36 months.
